PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Oral Potassium Lowers Clinic BP in Untreated Hypertension; Ambulatory Effect Remains Uncertain

potassium chlorideoral potassium supplementationhypertensionuntreated primary hypertensionblood pressureambulatory blood pressure monitoringmeta-analysisrandomized trialssodium-potassium balancehyperkalemiapreprint Cardiology

Background Information

Potassium supplements lower blood pressure in untreated hypertension.

Hypertension is a key risk factor for cardiovascular events, and managing blood pressure (BP) is essential in preventing these outcomes. Oral potassium reduced clinic systolic BP by 5.3 mm Hg and diastolic BP by 4.5 mm Hg in patients with untreated hypertension. While potassium supplementation could lower BP, the substantial heterogeneity and limited data on safety and ambulatory BP suggest cautious application. Oral potassium can modestly lower blood pressure in untreated hypertension, but further research is needed.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Ravichagua Ashiyama J, Medina FA, Loza C, Poterico J, Ramirez Sanchez S

Citation: Ravichagua Ashiyama J, Medina FA, Loza C, et al. Oral Potassium Supplementation Lowers Clinic Blood Pressure in Untreated Primary Hypertension-Systematic Review and Meta-Analysis of Randomized Trials. Journal of the American Heart Association. 2026;15(21):e048590. doi:10.1161/JAHA.125.048590

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.